LEISHMANIASIS
Diagnosis, Diagnostics, Immunodiagnosis &
Immunodiagnostics:
9896.
Allahverdiyev AM, Uzun S, Bagirova M, Durdu M, Memisoglu HR. A sensitive
new microculture method for diagnosis of cutaneous leishmaniasis. Am J Trop Med
Hyg. 2004 Mar;70(3):294-7.
9897.
Cortes S, Rolao N, Ramada J, Campino L. PCR as a rapid and sensitive tool
in the diagnosis of human and canine leishmaniasis using Leishmania donovani s.l.-specific
kinetoplastid primers. Trans R Soc Trop Med Hyg. 2004 Jan;98(1):12-7.
9898.
Costa DJ, Favali C, Clarencio J, Afonso L, Conceicao V, Miranda JC, Titus
RG, Valenzuela J, Barral-Netto M, Barral A, Brodskyn CI.
Lutzomyia longipalpis salivary gland homogenate impairs cytokine
production and costimulatory molecule expression on human monocytes and
dendritic cells. Infect Immun. 2004 Mar;72(3):1298-305.
9899.
Hailu A, Pater JM, Kager PA, van der Poll T. Increased expression of HIV
co-receptor CXCR4 on CD4+ T-cells in patients with active visceral leishmaniasis.
Scand J Infect Dis. 2004;36(1):56-8.
9900.
Islam MZ, Itoh M, Mirza R, Ahmed I, Ekram AR, Sarder AH, Shamsuzzaman SM,
Hashiguchi Y, Kimura E. Direct agglutination test with urine samples for the
diagnosis of visceral leishmaniasis. Am J Trop Med Hyg. 2004 Jan;70(1):78-82.
9901.
Pal S, Aggarwal G, Haldar A, Majumdar A, Majumdar HK, Duttagupta S.
Diagnosis of symptomatic kala-azar by polymerase chain reaction using
patient's blood. Med Sci Monit. 2004 Jan;10(1):MT1-5.
9902.
Ravindran R, Anam K, Bairagi BC, Saha B, Pramanik N, Guha SK, Goswami RP,
Banerjee D, Ali N. Characterization of immunoglobulin G and its subclass
response to Indian kala-azar infection before and after chemotherapy. Infect
Immun. 2004 Feb;72(2):863-70.
9903.
Riera C, Fisa R, Udina M, Gallego M, Portus M. Detection of Leishmania
infantum cryptic infection in asymptomatic blood donors living in an endemic
area (Eivissa, Balearic Islands, Spain) by different diagnostic methods. Trans R
Soc Trop Med Hyg. 2004 Feb;98(2):102-10.
9904.
Wortmann
GW, Romero LI, Paz HM, Ortega-Barria E, Bayard V, Hochberg LP, Ryan JR.
Real-time polymerase chain reaction diagnosis of leishmaniasis in Panama from
both fresh and frozen tissue. Trans R Soc Trop Med Hyg. 2004 Mar;98(3):148-51.
Pathogenesis:
9905.
Amprey JL, Spath GF, Porcelli SA. Inhibition of CD1 expression in human
dendritic cells during intracellular infection with Leishmania donovani. Infect
Immun. 2004 Jan;72(1):589-92.
9906.
Colmenares M, Corbi AL, Turco SJ, Rivas L. The dendritic cell receptor
DC-SIGN discriminates among species and life cycle forms of Leishmania. J
Immunol. 2004 Jan 15;172(2):1186-90.
9907.
Maes L, Vanden Berghe D, Germonprez N, Quirijnen L, Cos P, De Kimpe N,
Van Puyvelde L. In vitro and in vivo activities of a triterpenoid saponin
extract (PX-6518) from the plant Maesa balansae against visceral leishmania
species. Antimicrob Agents Chemother. 2004 Jan;48(1):130-6.
9908.
Milleron RS, Mutebi JP, Valle S, Montoya A, Yin H, Soong L, Lanzaro GC.
Antigenic diversity in maxadilan, a salivary protein from the sand fly vector of
American visceral leishmaniasis. Am J Trop Med Hyg. 2004 Mar;70(3):286-93.
9909.
Nylen S, Maasho K, McMahon-Pratt D, Akuffo H. Leishmanial amastigote
antigen P-2 induces major histocompatibility complex class II-dependent natural
killer-cell reactivity in cells from healthy donors. Scand J Immunol. 2004
Mar;59(3):294-304.
9910.
Tintaya KW, Ying X, Dedet JP, Rijal S, De Bolle X, Dujardin JC. Antigen
genes for molecular epidemiology of leishmaniasis: polymorphism of cysteine
proteinase B and surface metalloprotease glycoprotein 63 in the Leishmania
donovani complex. J Infect Dis. 2004 Mar 15;189(6):1035-43.
Vaccines
9911.
Das P. Infectious disease surveillance update. Lancet Infect Dis. 2004
Feb;4(2):69.
Therapy
9912.
Nylen S, Maasho K, McMahon-Pratt D, Akuffo H. Leishmanial amastigote
antigen P-2 induces major histocompatibility complex class II-dependent natural
killer-cell reactivity in cells from healthy donors. Scand J Immunol. 2004
Mar;59(3):294-304.